Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the …
A Ziman, M Mitri, E Klapper, SH Pepkowitz… - …, 2005 - Wiley Online Library
BACKGROUND: Thrombotic thrombocytopenic purpura (TTP) was once a highly fatal
disease with mortality reaching nearly 95 percent; however, application of therapeutic …
disease with mortality reaching nearly 95 percent; however, application of therapeutic …
A randomized controlled trial comparing standard-and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia
NM Heddle, RJ Cook, A Tinmouth… - Blood, The Journal …, 2009 - ashpublications.org
A noninferiority study was performed comparing low-dose and standard-dose prophylactic
platelet transfusions. A double-blind randomized controlled trial (RCT) was performed in 6 …
platelet transfusions. A double-blind randomized controlled trial (RCT) was performed in 6 …
[HTML][HTML] SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
M Dogan, L Kozhaya, L Placek, C Gunter… - Communications …, 2021 - nature.com
Abstract Development of antibody protection during SARS-CoV-2 infection is a pressing
question for public health and for vaccine development. We developed highly sensitive …
question for public health and for vaccine development. We developed highly sensitive …
Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients
J Kahwaji, E Barker, S Pepkowitz… - Clinical Journal of the …, 2009 - journals.lww.com
Abstract Background and objectives: Intravenous Ig (IVIG) is used in renal transplantation for
desensitization and treatment of antibody-mediated rejection (AMR). The infusion of high …
desensitization and treatment of antibody-mediated rejection (AMR). The infusion of high …
Platelet-rich plasma for the replenishment of bone
J Iqbal, SH Pepkowitz, E Klapper - Current osteoporosis reports, 2011 - Springer
This review examines the use of platelet-rich plasma (PRP) in the treatment of bone injuries
and to stimulate bone formation. Studies examining both in vivo bone healing and in vitro …
and to stimulate bone formation. Studies examining both in vivo bone healing and in vitro …
Management of familial hypertriglyceridemia during pregnancy with plasma exchange
P Sivakumaran, SW Tabak, K Gregory… - Journal of Clinical …, 2009 - Wiley Online Library
Hypertriglyceridemia‐induced pancreatitis is a serious complication of familial
dyslipidemias. Hormonal influences during pregnancy can compromise otherwise controlled …
dyslipidemias. Hormonal influences during pregnancy can compromise otherwise controlled …
Transfusion Practice: Toward extended phenotype matching: a new operational paradigm for the transfusion service
E Klapper, Y Zhang, P Figueroa, P Ness, J Stubbs… - …, 2010 - Wiley Online Library
BACKGROUND: Conventional pretransfusion testing uses hemagglutination to ensure
donor‐recipient compatibility for ABO/D status and recipient alloantibodies. While screening …
donor‐recipient compatibility for ABO/D status and recipient alloantibodies. While screening …
Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant
L Benck, EP Kransdorf, DA Emerson… - The Journal of Heart and …, 2021 - Elsevier
Background Primary graft dysfunction (PGD) is a major cause of early mortality following
heart transplant (HT). The International Society for Heart and Lung Transplantation (ISHLT) …
heart transplant (HT). The International Society for Heart and Lung Transplantation (ISHLT) …
Extracorporeal photopheresis in heart transplant rejection
J Patel, E Klapper, H Shafi, JA Kobashigawa - Transfusion and Apheresis …, 2015 - Elsevier
Up to 25% of heart transplant recipients develop rejection requiring intervention. While the
majority respond to augmentation of immunomodulatory drug therapy, a subset of patients …
majority respond to augmentation of immunomodulatory drug therapy, a subset of patients …
Blood group O convalescent plasma donations have significantly lower levels of SARS‐CoV‐2 IgG antibodies compared to blood group A donations
C Hayes, W Rubenstein, D Gibb, E Klapper… - …, 2021 - Wiley Online Library
Background COVID‐19 convalescent plasma (CCP) is plasma collected from individuals
who have recovered from SARS‐CoV‐2 infection. The FDA Emergency Use Authorization …
who have recovered from SARS‐CoV‐2 infection. The FDA Emergency Use Authorization …